메뉴 건너뛰기
Journal of Thoracic Oncology
Volumn 8, Issue 8, 2013, Pages
"one marker does not fit all": Additional translational and validation studies are needed to identify faithful predictors of pemetrexed activity in mesothelioma
Author keywords

[No Author keywords available]
Indexed keywords

CARBOPLATIN; CISPLATIN; FOLYLPOLYGLUTAMATE SYNTHASE; MESSENGER RNA; PEMETREXED; REDUCED FOLATE CARRIER;
EID: 84880906394     PISSN: 15560864     EISSN: 15561380     Source Type: Journal    
DOI: 10.1097/JTO.0b013e318293e45b     Document Type: Letter
Times cited : (2)
References (5)
  • 1
    • 84876410828 scopus 로고    scopus 로고
    • Reduced folate carrier and folylpolyglutamate synthetase, but not thymidylate synthase predict survival in pemetrexed-treated patients suffering from malignant pleural mesothelioma
    • Mairinger F, Vollbrecht C, Halbwedl I, et al. Reduced folate carrier and folylpolyglutamate synthetase, but not thymidylate synthase predict survival in pemetrexed-treated patients suffering from malignant pleural mesothelioma. J Thorac Oncol. 2013;8:644-653.
    • (2013) J Thorac Oncol. , vol.8 , pp. 644-653
    • Mairinger, F.1    Vollbrecht, C.2    Halbwedl, I.3
  • 2
    • 79954607787 scopus 로고    scopus 로고
    • Thymidylate synthase and excision repair cross-complementing group-1 as predictors of responsiveness in mesothelioma patients treated with pemetrexed/carboplatin
    • Zucali PA, Giovannetti E, Destro A, et al. Thymidylate synthase and excision repair cross-complementing group-1 as predictors of responsiveness in mesothelioma patients treated with pemetrexed/carboplatin. Clin Cancer Res 2011;17:2581-2590.
    • (2011) Clin Cancer Res , vol.17 , pp. 2581-2590
    • Zucali, P.A.1    Giovannetti, E.2    Destro, A.3
  • 3
    • 77951894575 scopus 로고    scopus 로고
    • Thymidylate synthase but not excision repair cross-complementation group 1 tumor expression predicts outcome in patients with malignant pleural mesothelioma treated with pemetrexed-based chemotherapy
    • Righi L, Papotti MG, Ceppi P, et al. Thymidylate synthase but not excision repair cross-complementation group 1 tumor expression predicts outcome in patients with malignant pleural mesothelioma treated with pemetrexed-based chemotherapy. J Clin Oncol 2010;28:1534-1539.
    • (2010) J Clin Oncol , vol.28 , pp. 1534-1539
    • Righi, L.1    Papotti, M.G.2    Ceppi, P.3
  • 4
    • 84875388106 scopus 로고    scopus 로고
    • Thymidylate synthase and folyl-polyglutamate synthase are not clinically useful markers of response to pemetrexed in patients with malignant pleural mesothelioma
    • Lustgarten DE, Deshpande C, Aggarwal C, et al. Thymidylate synthase and folyl-polyglutamate synthase are not clinically useful markers of response to pemetrexed in patients with malignant pleural mesothelioma. J Thorac Oncol 2013;8:469-477.
    • (2013) J Thorac Oncol , vol.8 , pp. 469-477
    • Lustgarten, D.E.1    Deshpande, C.2    Aggarwal, C.3
  • 5
    • 66049102881 scopus 로고    scopus 로고
    • Aberrant splicing of folylpolyglutamate synthetase as a novel mechanism of antifolate resistance in leukemia
    • Stark M, Wichman C, Avivi I, Assaraf YG. Aberrant splicing of folylpolyglutamate synthetase as a novel mechanism of antifolate resistance in leukemia. Blood 2009;113: 4362-4369.
    • (2009) Blood , vol.113 , pp. 4362-4369
    • Stark, M.1    Wichman, C.2    Avivi, I.3    Assaraf, Y.G.4

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.